Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 1Cohance Lifesciences
02 1Jai Radhe Sales
03 1Pharm-RX Chemical
04 1Chynops Pharma
05 1HRV Global Life Sciences
06 1Nortec Quimica
07 1CTX Lifesciences
08 1Globela Pharma
09 1Lusochimica
10 2Siegfried AG
01 1Brazil
02 6India
03 1Italy
04 2Switzerland
05 1U.S.A
01 2Active
02 2Inactive
03 7Blank
01 2Valid
02 9Blank
01 1220MF10107
02 10Blank
01 1WC-0097
02 10Blank
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Chynops Pharma is an ideal sourcing partner for high-quality APIs, advanced intermediates, speciality chemicals & excipients.
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-02-15
Pay. Date : 2019-02-11
DMF Number : 8940
Submission : 1991-01-18
Status : Active
Type : II
NDC Package Code : 65724-4503
Start Marketing Date : 2010-03-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-09-18
Pay. Date : 2013-01-04
DMF Number : 22401
Submission : 2008-12-10
Status : Active
Type : II
Certificate Number : R1-CEP 2008-324 - Rev 03
Issue Date : 2018-05-18
Type : Chemical
Substance Number : 943
Status : Valid
Date of Issue : 2022-06-24
Valid Till : 2025-07-02
Written Confirmation Number : WC-0097
Address of the Firm :
NDC Package Code : 42419-005
Start Marketing Date : 2008-12-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4230
Submission : 1981-06-15
Status : Inactive
Type : II
Certificate Number : R1-CEP 2008-064 - Rev 02
Issue Date : 2021-01-15
Type : Chemical
Substance Number : 943
Status : Valid
Registration Number : 220MF10107
Registrant's Address : Karlstrasse 15, 32423, Minden, Federal Republic of Germany
Initial Date of Registration : 2008-04-11
Latest Date of Registration : --
NDC Package Code : 65724-4503
Start Marketing Date : 2010-03-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4290
Submission : 1981-10-08
Status : Inactive
Type : II
A Oxymetazoline Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxymetazoline Hydrochloride, including repackagers and relabelers. The FDA regulates Oxymetazoline Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxymetazoline Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oxymetazoline Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Oxymetazoline Hydrochloride supplier is an individual or a company that provides Oxymetazoline Hydrochloride active pharmaceutical ingredient (API) or Oxymetazoline Hydrochloride finished formulations upon request. The Oxymetazoline Hydrochloride suppliers may include Oxymetazoline Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Oxymetazoline Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 10 companies offering Oxymetazoline Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?